
    On Tuesday, April 19, 2016, the President signed into law:
S. 192, the "Older Americans Act Reauthorization Act of 2016," which reauthorizes and modifies grant programs for services to the elderly under the Older Americans Act of 1965;
S. 483, the "Ensuring Patient Access and Effective Drug Enforcement Act of 2016," which amends the Controlled Substances Act to: define "imminent danger to public health or safety" for the purposes of an immediate suspension or revocation by the Department of Justice (DOJ) of a registration to manufacture, distribute, or dispense controlled substances; and provide registrants with the opportunity to submit a corrective action plan prior to a determination by DOJ to deny or revoke a registration; and
S. 2512, the "Adding Zika Virus to the FDA Priority Review Voucher Program Act," which adds Zika virus to the Food and Drug Administration priority review voucher program to encourage the development of treatments for neglected tropical diseases.
  